Device Week, Sept. 13, 2018 – A Big Week For LivaNova; Creavo Seeks Cardiac Test Breakthrough

In this edition of Device Week, Medtech Insight’s Reed Miller talks to editor David Filmore about the latest good news for LivaNova and London-based reporter Catherine Longworth provides and update on Creavo Medical, a UK-based company using an old technology for a new kind of cardiac diagnostic that could save hospitals a lot of money in the treatment of patients suspected of having a heart attack. For more information on Medtech Insight and to start a free trial https://medtech.pharmaintelligence.informa.com/subscribe Start-Up Spotlight: Creavo Medical, Diagnosing Myocardial Ischaemia With MCG NICE Endorses Sutureless Aortic Valves While LivaNova Reaches Study Milestone TRD Societal Cost Can Sway US Payer On VNS Coverage Decision